<color><param>0100,0100,0100</param>Following are the next series of Wolfson Institute Seminars
September-November 2000, held on Tuesdays at 4pm:
<bold>26 September Dr John Danesh
University of Oxford
Emerging risk factors in coronary heart disease.</bold>
In recent years, a variety of novel risk factors related to persistent
infection, inflammation, haemostasis or other processes have been
proposed to be relevant to coronary heart disease in the general
population. This presentation will review the strengths and
limitations of the available evidence for several of these hypotheses.
<bold>10 October Professor Klaus Trott
St Bartholomew's Hospital
Thyroid disease in the Marshall Islands and the A-bomb tests
on Bikini</bold>.
The Marshallese population probably has the highest rate of thyroid
cancer ever reported (1.5%). The United States tested 66 nuclear
weapons between 1946 and 1954 on Bikini and Enewetak in the
Marshall Islands. This seminar summarises the results of an
extensive study conducted between 1991 and 1995 to determine
the radioactive contamination of all atolls in the Marshall islands.
<bold>31 October Dr Malcolm Law
Wolfson Institute, St Bartholomew's &
The Royal London
Passive smoking and heart disease </bold>
Breathing other people's cigarette smoke is an important and
avoidable cause of ischaemic heart disease, increasing a
nonsmoker's risk by a quarter. In this seminar the evidence for the
causal association will be presented and a possible biological
mechanism.
<bold>24 October Dr Sylvia Dobbs
Therapeutics in the Elderly Research
Group
Parkinsonism: thinking the unthinkable in the current anti-
academic climate.</bold>
Passing the routine diagnostic threshold for clinical idiopathic
Parkinsonism may represent the tip of the iceberg. An alternative
to the binomial classification of the disease status, where diversity
and a preclinical state are recognised, is proposed. Using objective
measures to its facets, it is feasible to define the tendency towards
Parkinsonism and the disease burden beyond that threshold. This
approach has been used to examine the associations and
biological gradients with potential environmental insults.
<bold>21 November Dr David Horrobin
Laxdale Ltd, Scotland
Innovation in the pharmaceutical industry</bold>
Effective innovation in the pharmaceutical industry is failing and this
is a major reason for mergers of major companies. Reasons for
failure include a lack of support for creative individuals and for
clinical research and a huge investment in unproven new
technologies like combinatorial chemistry, high throughput
screening and genomics. Genomics is highly unlikely to lead to
the much-touted benefits.
All are welcome.
Nearest underground stations are Barbican and Farringdon.
<nofill>
Allan Hackshaw
Lecturer in Epidemiology & Medical Statistics
Wolfson Institute of Environmental & Preventive Medicine
St Bartholomew's & The Royal London School of Medicine & Dentistry
Queen Mary & Westfield College, University of London
Charterhouse Square
London EC1M 6BQ
Telephone: (+44) (020) 7982 6283
Fax: (+44) (020) 7982 6270
email: [log in to unmask]
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|